Clinical Trials Browser

Phase 1/2 × donafenib × Gastrointestinal × Clear all

NCT02489201 2023-06-15

A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer

Phase 1/2 Terminated

Gastrointestinal

Esophageal Neoplasms

NCT04979663 2021-08-09

GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer

Phase 1/2 Unknown

Gastrointestinal

Biliary Tract Carcinoma

NCT02489916 2016-01-05

Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms